Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.
Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check6 days agoChange DetectedNo significant changes to the study record were observed. Updates seem to be routine informational additions, such as new publications, and minor formatting changes.SummaryDifference0.1%
- Check13 days agoChange DetectedThe study locations have been updated to 28 sites, with Oregon Health & Science University (Portland, OR) and Lundquist Institute at Harbor-UCLA (Torrance, CA) removed from the list.SummaryDifference0.4%
- Check20 days agoChange DetectedPublications section description updated to reflect that publications are automatically filled in from PubMed, using revised wording. Page revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoval of the general operating status notice about government funding and NIH Clinical Center. This change does not affect study details or the information presented about the trial; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check35 days agoChange DetectedThe study locations list now shows 30 sites, with Stanford, CA removed, changing the total number of locations from 31 to 30.SummaryDifference0.4%
- Check42 days agoChange DetectedThe screenshots show changes limited to layout and UI elements with no modification to core study content such as title, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.